INARI MEDICAL INC (NARI)
US45332Y1091 - Common Stock
INARI MEDICAL INC
NASDAQ:NARI (5/17/2024, 7:15:32 PM)
After market: 45.75 0 (0%)45.75
-0.55 (-1.19%)
Company Profile
Inari Medical, Inc. operates as a medical device company. The company is headquartered in Irvine, California and currently employs 1,100 full-time employees. The company went IPO on 2020-05-22. The Company’s products primarily consist of ClotTriever and FlowTriever systems, which are catheter-based mechanical thrombectomy systems that are used for the treatment of the venous thromboembolism (VTE) deep vein thrombosis (DVT), and pulmonary embolism (PE). Its InThrill system is used for the removal of thrombus from the peripheral vasculature. Its ProTrieve sheath is used for the removal of thrombus from the peripheral vasculature through aspiration. The company also offers RevCore thrombectomy catheter, which is a thrombectomy device for venous stent thrombosis, Triever 16 Curve catheter, which is used for venous thrombus removal, and ClotTriever Bold catheter, which is used for DVT and the removal of acute and chronic clots in the peripheral vasculature. Its ClotTriever XL, which is a catheter for efficient clot removal with minimal blood loss. The company also offers LimFlow System for Transcatheter Arterialization of the Deep Veins (TADV).
Company Info
INARI MEDICAL INC
6001 Oak Canyon, Suite 100
Irvine CALIFORNIA 92618
P: 19499234747
CEO: William Hoffman
Employees: 1100
Website: https://www.inarimedical.com
NARI News
10 hours ago - Robbins LLPInari Medical, Inc. Investor Notice: Robbins LLP Remind Stockholders of the NARI Securities Fraud Class Action
a day ago - TheNewswire.comROSEN, A LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARIWHY: NEW YORK, NY - (NewMediaWire) - May 16, 2024 - Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24, 2022 and February 28, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than July 12, 2024.
a day ago - NewMediaWireROSEN, A LEADING LAW FIRM, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NARISearch for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
a day ago - Glancy Prongay & Murray LLPGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) Investors
a day ago - Kessler Topaz Meltzer & Check, LLPNASDAQ: NARI: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Securities Class Action Lawsuit Filed Against Inari Medical, Inc.
a day ago - Law Offices of Howard G. SmithINVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Inari Medical, Inc. (NARI) InvestorsNARI Twits
Here you can normally see the latest stock twits on NARI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
